ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

NTP Board Approves $4 Million Mouse Variation Concept

November 22, 1985

FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer

October 30, 1998

ACS Elects New Volunteer Leaders

November 19, 2010